Search & Analyze

Alkem Laboratories Ltd.

HealthcarePharmaceuticals & Drugs

www.alkemlabs.com BSE: 539523NSE: ALKEM

₹5,180.00BSE0.65%

07 Sep, 4:01 PM

₹5,180.00

₹61.93K Cr

28.71

4.33

18.29%

₹5,220.00

₹5,110.00

₹5,933.00

₹5,085.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
LUPIN LTD. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
Alkem Laboratories Ltd. ALKEM	5,180.00	28.71	61,934.67	1.02	520.98	-22.00%	3,740.15	10.95%	21.28

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,935.82	3,031.82	3,414.67	3,374.28	3,143.75	3,371.14	4,000.99	3,736.82	3,603.32	3,740.15
Expenses	2,533.84	2,423.18	2,661.84	2,614.89	2,752.46	2,632.09	3,080.22	2,908.82	3,085.93	2,974.10
	401.98	608.64	752.83	759.39	391.29	739.05	920.77	828.00	517.39	766.05
	13.69%	20.08%	22.05%	22.51%	12.45%	21.92%	23.01%	22.16%	14.36%	20.48%
	75.65	120.31	134.48	92.99	145.96	149.42	103.69	90.31	65.10	152.75
Interest	26.86	29.11	28.14	36.03	28.42	29.78	35.02	42.10	53.88	46.62
	83.43	80.48	78.91	85.28	112.49	87.68	93.61	95.01	105.76	100.19
	367.34	619.36	780.26	731.07	395.72	770.60	895.34	780.70	422.28	771.48
	17.11%	11.16%	10.04%	12.35%	18.53%	13.33%	12.98%	16.35%	40.53%	32.47%
	293.56	545.16	688.64	625.82	305.86	664.26	765.06	636.02	236.46	519.96
	24.56	45.60	57.60	52.35	25.58	55.56	64.00	53.20	19.78	43.49

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	15,274.85	17,939.07	19,383.96	19,302.96	22,567.84
	10,634.19	11,599.26	12,667.58	12,964.52	14,712.27
EXPENDITURE :
Increase/Decrease in Stock	-535.48	462.37	14.12	-190.13	-167.12
Raw Material Consumed	4,101.26	3,919.06	4,312.94	4,311.38	4,713.91
Power & Fuel Cost	162.96	163.94	162.58	168.99	171.03
Employee Cost	1,962.71	2,131.35	2,201.01	2,453.92	2,837.11
Other Manufacturing Expenses	1,092.63	972.37	1,183.76	1,282.95	1,178.22
General and Administration Expenses	641.25	819.84	833.21	850.62	1,114.27
Selling and Distribution Expenses	1,070.10	1,339.88	1,307.60	1,319.76	1,550.12
Miscellaneous Expenses	85.84	181.00	406.87	254.88	320.43
	8,581.27	9,989.81	10,422.09	10,452.37	11,717.97
Operating Profit (Excl OI)	2,052.92	1,609.45	2,245.49	2,512.15	2,994.30
	162.65	216.08	310.84	493.74	594.26
	2,215.57	1,825.53	2,556.33	3,005.89	3,588.56
Interest	52.37	107.36	112.41	121.70	160.78
PBDT	2,163.20	1,718.17	2,443.92	2,884.19	3,427.78
	303.96	310.42	299.30	357.16	382.06
Profit Before Taxation & Exceptional Items	1,859.24	1,407.75	2,144.62	2,527.03	3,045.72
Exceptional Income / Expenses	-14.96	-102.98	-121.49		-174.83
	1,844.28	1,304.77	2,023.13	2,527.03	2,870.89
Provision for Tax	163.96	297.96	211.67	311.03	517.76
	1,680.32	1,006.81	1,811.46	2,216.00	2,353.13
Extra items				0.00	0.00
Minority Interest	-34.70	-22.64	-15.69	-49.90	-49.36
Share of Associate				-0.62	-1.97
Consolidated Net Profit	1,645.62	984.17	1,795.77	2,165.48	2,301.80
Profit Balance B/F	5,366.75	6,593.89	7,051.97	8,309.70	9,973.01
Appropriations	7,012.37	7,578.06	8,847.74	10,475.18	12,274.81
Equity Dividend %	1,700.00%	2,500.00%	2,000.00%	2,250.00%	2,650.00%
	137.65	82.32	150.21	181.14	192.54
Adjusted EPS	137.65	82.32	150.21	181.14	192.54

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	23.91	23.91	23.91	23.91	23.91
Share Warrants & Outstandings	0.60	0.60	19.54	36.15	35.54
Total Reserves	8,613.39	9,020.78	10,268.61	11,924.81	13,760.65
Reserve excluding Revaluation Reserve	8,613.39	9,020.78	10,268.61	11,924.81	13,760.65
	8,637.90	9,045.29	10,312.06	11,984.87	13,820.10
Minority Interest	209.43	389.71	402.34	448.76	528.83
Secured Loans	0.03		40.00	62.42	39.61
Unsecured Loans	9.35			248.49	452.84
Deferred Tax Assets / Liabilities	-1,309.26	-1,302.50	-1,514.83	-1,738.25	-1,804.23
Other Long Term Liabilities	74.39	245.14	526.09	641.38	802.56
Long Term Provisions	332.75	369.36	299.86	338.22	431.21
Total Non-Current Liabilities	-892.74	-688.00	-648.88	-447.74	-78.01
Trade Payables	1,173.38	1,165.03	1,748.12	1,937.35	2,244.18
Other Current Liabilities	771.42	838.81	891.94	1,068.22	1,186.08
Short Term Borrowings	2,570.62	1,307.12	1,172.63	734.89	1,085.25
Short Term Provisions	289.92	396.19	181.86	220.21	267.19
Total Current Liabilities	4,805.34	3,707.15	3,994.55	3,960.67	4,782.70
Total Liabilities	12,759.93	12,454.15	14,060.07	15,952.85	19,053.62
Gross Block	4,185.64	4,050.24	4,543.69	4,719.78	6,069.65
Less: Accumulated Depreciation	1,283.91	1,367.39	1,670.91	1,867.47	2,198.62
Net Block	2,901.73	2,682.85	2,872.78	2,852.31	3,871.03
Capital Work in Progress	339.48	310.27	148.40	476.55	137.91
Non Current Investments	231.67	304.61	334.80	943.24	1,131.50
Long Term Investment	231.67	304.61	334.80	943.24	1,131.50
Long Term Loans & Advances	154.44	139.07	203.74	277.96	363.58
Other Non Current Assets	697.18	274.70	78.60	385.45	1,195.20
Total Non-Current Assets	4,324.50	3,724.47	3,648.49	5,007.03	6,843.10
Currents Investments	139.31	317.21	148.99	902.26	737.31
Inventories	3,005.53	2,607.53	2,661.18	2,922.41	3,333.22
Sundry Debtors	1,884.60	2,132.18	2,252.81	2,466.25	2,979.11
Cash and Bank	2,578.58	2,616.89	1,579.35	1,563.08	1,732.90
Other Current Assets	239.80	244.68	237.13	156.28	221.20
Short Term Loans and Advances	585.88	687.93	3,532.12	2,800.91	3,206.78
Total Current Assets	8,433.70	8,606.42	10,411.58	10,811.19	12,210.52
Net Current Assets (Including Current Investments)	3,628.36	4,899.27	6,417.03	6,850.52	7,427.82
Total Assets	12,759.93	12,454.15	14,060.07	15,952.85	19,053.62
Contingent Liabilities	268.63	284.57	91.71	881.05	1,113.14
Total Debt	2,580.12	1,307.15	1,213.97	1,062.79	1,623.50
	722.48	756.56	860.94	999.47	1,153.04
Adjusted Book Value	722.48	756.56	860.94	999.47	1,153.04

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	1,844.28	1,304.77	2,023.13	2,527.03	2,870.89
Adjustment	208.60	324.35	383.57	103.80	136.33
Changes In working Capital	-544.96	326.77	-51.69	-213.97	-415.17
Cash Flow after changes in Working Capital	1,507.92	1,955.89	2,355.01	2,416.86	2,592.05
Cash Flow from Operating Activities	1,111.02	1,682.50	1,948.07	1,912.84	1,963.03
Cash Flow from Investing Activities	-1,435.13	112.84	-1,008.50	-1,298.76	-1,667.21
Cash Flow from Financing Activitie	379.57	-1,760.82	-1,145.01	-810.99	-503.40
Net Cash Inflow / Outflow	55.46	34.52	-205.44	-196.91	-207.58
Opening Cash & Cash Equivalents	174.22	232.18	273.80	66.31	-120.09
Effect of Foreign Exchange Fluctuations	2.50	7.10	-2.05	10.51	-14.46
Closing Cash & Cash Equivalent	232.18	273.80	66.31	-120.09	-342.13

Ratios

Valuation

28.71

4.33

17.02

4.11

180.45

1,196.51

Profitability

18.29

21.28

13.44

13.27

10.43

Leverage & Liquidity

0.12

2.55

18.86

Returns

1.02

1.29

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	56.38	55.66	55.66	55.13	53.04	51.20	51.20	51.20	49.70
	27.26	28.23	28.16	28.83	30.91	31.41	31.51	31.55	33.04
	16.36	16.10	16.18	16.05	16.05	17.40	17.30	17.25	17.25
	43.62	44.34	44.34	44.87	46.96	48.80	48.80	48.80	50.30
No. of Shareholders	69,627	74,744	84,038	84,326	79,740	67,196	64,536	62,835	62,822

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-30	AGM
2026-07-21	Board Meeting	Quarterly Results
2026-05-29	Ex Dividend	Rs.10.0000 per share(500%)Final Dividend	2026-08-07	2026-08-07

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Alkem Laboratories Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Basudeo N Singh

Chairman

₹21.70 Cr

Mar '26

Sandeep Singh

Managing Director

₹7.89 Cr

Mar '26

Mritunjay Kumar Singh

Executive Director

₹11.31 Cr

Mar '26

Madhurima Singh

Executive Director

₹11.15 Cr

Mar '26

Sarvesh Singh

Executive Director

₹4.54 Cr

Mar '26

Srinivas Singh

Executive Director

₹10.72 Cr

Mar '26

Narendra Kumar Aneja